MedTrace Logo

Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment

NCT03348735 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2021-04-28

No results posted yet for this study

Summary

Evaluation of topical treatment with lidocaine 5% patch (daily administration) or capsaicin 8% patch (periodic administration - upon reoccurrence of pain symptoms) in adult patients suffering from localized neuropathic pain (LNP) across a wide variety of etiologies, with a duration between 1 and 24 months (subacute to chronic neuropathic pain (NP)).

Conditions

  • Neuropathic Pain

Interventions

DRUG

Lidocaine patch 5%

Application of Lidocaine 5% patch for 12 hours.

DRUG

Capsaicin 8% Patch

Application of Capsaicin 8% patch for

DRUG

Pregabalin

Oral treatment with pregabalin (75mg capsules) will be used at optimized doses to best match clinical practice in Europe.

Sponsors & Collaborators

  • University Hospital, Antwerp

    lead OTHER

Principal Investigators

  • Guy Hans, MD, PhD · University Hospital, Antwerp

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-03
Primary Completion
2021-04-19
Completion
2021-04-19

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03348735 on ClinicalTrials.gov